0.00Open0.00Pre Close0 Volume0 Open Interest20.00Strike Price0.00Turnover0.00%IV41.83%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier22DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma15.28Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Scholar Rock Stock Discussion
Breakthrough: Scholar Rock's SMA Drug Shows 30.4% Patient Improvement in Phase 3 Trial
Scholar Rock's $437M War Chest: Can Their SMA Drug Deliver Returns for Investors?
Can This Phase 3 SMA Drug Transform Muscle Disease Treatment? Key Data Coming at MDA Conference
No comment yet